Navigation Links
Genelex Receives First Patent on Business Methods for Pharmacogenetics
Date:8/1/2012

SEATTLE, Aug. 1, 2012 /PRNewswire/ -- Genelex Corporation today announced the acceptance of US Patent 8,099,298 titled, "Genetic Data Analysis and Database Tools." Genelex's patent, filed in early 2007, covers a variety of innovations for genetic analysis and interpretation, personalized prescribing, electronic medical records processing, and online reimbursement.

Notably covered are the algorithms which analyze and interpret patient specific pharmacogenetic and pharmacological information. These algorithms provide actionable insight into drug-drug and drug-gene interactions and are the backbone of comprehensive medication management reports and recommendations. These sophisticated software tools enable selection at the point-of-care of the safest and most effective drug and dose combinations for patients.

"The USPTO's issuance of this patent further demonstrates our leadership position in the rapidly growing Pharmacogenetics marketplace," stated Howard Coleman, Chief Executive Officer of Genelex. "Everyday prescribers call on us to help prevent and reduce adverse drug events improving and saving patient's lives and saving healthcare dollars."

Genelex has additional patents pending and continues to strengthen its Pharmacogenetics intellectual property and business model leadership.

About Genelex
Headquartered in Seattle, Genelex provides advanced decision support tools and genetic tests that help healthcare providers choose the safest, most effective medication regimens for their patients. Our personalized prescribing system takes the guesswork out of medication management and can reduce the incidence of adverse drug events, saving lives and healthcare dollars. For more information, please visit www.genelex.com.


'/>"/>
SOURCE Genelex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
3. Nephros Receives 510(k) Clearance for Hemodiafiltration System
4. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
5. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
6. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Alexza Receives Complete Response Letter for Adasuve™ NDA
9. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
10. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
11. New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... DUBLIN , Dec 2, 2016 Research ... Pipeline Database" newsletter to their offering. ... , , ... La Merie Publishing,s proprietary R&D Drug Pipeline Database provides 24/7 online ... therapeutic drugs on the market and on investigational drug candidates in ...
(Date:12/2/2016)... the largest share in the ECG Cables And ECG Leadwires ... remote monitoring ECG devices. On the other hand, the ... the highest growth rate during the forecast period. ... Company (U.S.), Medtronic plc ( Ireland ), Koninklijke ... Medical International Limited ( China ), held major ...
(Date:12/2/2016)... Quantum Radiology,s Mobile Breast Center (QR MBC) brings cutting-edge ... at the workplace, thereby maximizing convenience and compliance.  QR ... and SunTrust Bank, and community health groups to provide ... "I think it,s a great service for ... a mammogram without taking a large amount of time ...
Breaking Medicine Technology:
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... The annual ... Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who ... C) or prescription drug plan (Part D) need to make changes during this period ...
(Date:12/2/2016)... Hills, CA (PRWEB) , ... December 02, 2016 ... ... reconstructive surgeon in Beverly Hills, California, will be included in the 2016 “Guide ... given to exceptional professionals based on the amalgamation of their education, experience, and ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering local frontline ... field of pain management. , The demand for supplemental training related to ...
(Date:12/2/2016)... Texas (PRWEB) , ... December 02, 2016 , ... Yisrayl ... that delves into how this current generation fits into Bible Prophecy. Yisrayl says this ... various facts pointing to this conclusion, showing how the details line up exactly with ...
Breaking Medicine News(10 mins):